A carregar...

Drug Industry Groups Oppose FDA “Quality Metrics” Plan: The Agency Wants to Use Manufacturing Data to Attack Drug Shortages

Raising their voices in nearly unanimous opposition, pharmaceutical manufacturers and their suppliers have mounted a campaign to dissuade the FDA from launching a voluntary program in 2018 that is aimed at reducing drug shortages.

Na minha lista:
Detalhes bibliográficos
Publicado no:P T
Autor principal: Barlas, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: MediMedia USA, Inc. 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5481295/
https://ncbi.nlm.nih.gov/pubmed/28674472
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!